FLC
IDYA icon

Fifth Lane Capital’s IDEAYA Biosciences IDYA Stock Holding History

Fifth Lane Capital’s Portfolio IDYA Stock Details IDYA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-12,500
Closed -$432K – 88
2025
Q4 		$432K Sell
12,500
-21,737
-63% -$693K 0.33% 49
2025
Q3 		$932K Buy
+34,237
New +$828K 0.94% 24

Other funds holding IDYA

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
LGM
Logos Global Management San Francisco, California $2B AUM 444.09% 1-Year Est. Return
Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return

Fifth Lane Capital's IDYA Position: Q1 2026 in Review

Fifth Lane Capital sold out of IDEAYA Biosciences (IDYA) in Q1 2026, closing a stake of 12,500 shares — an estimated $432K sold.

Fifth Lane Capital first reported a position in IDYA in Q3 2025 and held it in 2 quarters. The position peaked at $932K in Q3 2025. 253 funds tracked by Wall St. Rank hold IDYA as of Q1 2026.

  • Fifth Lane Capital reported no remaining IDEAYA Biosciences position as of Q1 2026 after selling out during the quarter.
  • Fifth Lane Capital sold 12,500 IDEAYA Biosciences shares in Q1 2026, an estimated $432K.
  • Fifth Lane Capital first reported a position in IDEAYA Biosciences in Q3 2025 and held it in 2 quarters.
  • Fifth Lane Capital's IDEAYA Biosciences position peaked at $932K in Q3 2025.
  • 253 funds tracked by Wall St. Rank held IDEAYA Biosciences as of Q1 2026.

Based on Fifth Lane Capital's 13F filing for Q1 2026, filed 15 May 2026.